A phase Ib study of oraxol in combination with ramucirumab in patients with gastric or esophageal cancers who failed previous chemotherapy.

Yi-Ping Hung,Yee Chao,Ming-Huang Chen,David J. Cutler,Douglas Kramer,Wing-Kai Chan,Rudolf Kwan,Noelyn Anne Hung,Tak Hung,Laura L. Tenner

A phase Ib study of oraxol in combination with ramucirumab in patients with gastric or esophageal cancers who failed previous chemotherapy.

2019

Yi-Ping Hung
Yee Chao
Ming-Huang Chen
David J. Cutler
Douglas Kramer
Wing-Kai Chan
Rudolf Kwan
Noelyn Anne Hung
Tak Hung
Laura L. Tenner

e15518Background: Oraxol consists of oral paclitaxel (PTX) administered with the novel P-glycoprotein inhibitor HM30181A which enables the oral absorption of PTX. Ramucirumab (RAM) + intravenous we...

Keywords:

Oncology
Pathology
Ramucirumab
Chemotherapy
Internal medicine
Medicine
in patient
Paclitaxel

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations